Xi'an-based hospital operator running general and specialty hospitals, part of a broader medical investment group.
Xi'an-based hospital operator running general and specialty hospitals, part of a broader medical investment group.
In one line: A Chinese regional hospital-group operator.
Moat: narrow (regulatory licence, scale). Regional hospital-operating licences and facility scale versus smaller clinics.
Headquarters: Xi'an, China · Employees: 8,055
Size Xi'an International Medical Investment (000516.SZ) is a China Health Care company (Hospital/Nursing Management) with a market value of $1.46B, the 1549th largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥4.39 on 18 Nov 2026.
Performance Over six months the shares fell 2.2%, against -6.9% for the median peer and -20.0% for the China market (cap-weighted) — 9th highest of 20 in its peer set.
Growth Revenue fell 1.1% over the last twelve months (peer median +11.9%); the operating margin is -1.6% (peer median 10.0%).
Valuation It trades at 3.1× enterprise value to sales against a peer median of 2.6× (10th most expensive of 21).
Price implies For today's price to make sense, revenue must grow about 13% a year for seven years (Req g). Recent delivered growth is +21%, so the hurdle is -8 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 2.1 points below its cost of capital (7.4% WACC).
Next results Next results expected around 29 Apr 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥4.16B | CN¥4.07B | CN¥4.82B | CN¥4.55B | CN¥2.71B |
| Revenue growth | — | -15% | +6% | +68% | — |
| Gross profit | CN¥943M | CN¥167M | CN¥278M | CN¥156M | -CN¥366M |
| EBITDA | n/a | CN¥415M | CN¥545M | CN¥454M | -CN¥264M |
| Net income | -CN¥89.8M | -CN¥313M | -CN¥254M | -CN¥368M | -CN¥1.18B |
| Free cash flow | CN¥1.11B | CN¥1.03B | CN¥463M | CN¥327M | -CN¥703M |
| Capital expenditure | CN¥207M | CN¥262M | CN¥548M | CN¥763M | CN¥1.19B |
| Total debt | CN¥3.94B | CN¥4.21B | CN¥4.64B | CN¥4.74B | CN¥4.46B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g |
|---|---|---|---|---|---|---|
| Xi'an International Medical Investment 000516.SZ | $1.46B | -2% | -1% | -2% | 3.1× | 12.7% |
| Topchoice Medical 600763.SS | $2.33B | -12% | +7% | 26% | 5.3× | 12.4% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 000516.SZ | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +0.5% | +1.6% | 8th lowest of 20 |
| 6-month return | -2.2% | -6.9% | 9th highest of 20 |
| Distance from 52-week high | -29.1% | -21.9% | 6th lowest of 21 |
| Revenue growth (TTM) | -1.1% | +11.9% | 3rd lowest of 21 |
| Operating margin | -1.6% | 10.0% | 3rd lowest of 21 |
| EV / Sales | 3.1× | 2.6× | 10th most expensive of 21 |
| Growth the price implies (Req g, 7 yrs) | 12.7% | 12.5% | 8th least demanding of 15 |
| Growth delivered (Del g) | +20.6% | +9.5% | 2nd highest of 15 |
| Hurdle (Req g minus delivered) | -7.9 pp | +4.8 pp | 5th least demanding of 15 |
| ROIC minus cost of capital | -2.1 pp | -2.7 pp | 10th highest of 21 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Xi'an International Medical Investment 000516.SZ | China | $1.46B | -2% | -1% | -2% | 3.1× | 12.7% | +20.6% |
| Aevis Victoria AEVS.SW | Switzerland | $1.43B | +8% | +15% | -6% | 1.8× | 26.5% | +10.2% |
| Rainbow Childrens Medicare RAINBOW.NS | India | $1.37B | -7% | +23% | 22% | 7.0× | 30.7% | +21.2% |
| Sanbo Hospital Management 301293.SZ | China | $1.35B | -29% | +17% | 6% | 4.9× | n/a | n/a |
| Sienna Senior Living SIA.TO | Canada | $1.58B | -8% | +15% | 10% | 3.1× | 18.9% | +8.6% |
| Spire Healthcare SPI.L | United Kingdom | $1.31B | +11% | +2% | 8% | 1.4× | 10.0% | +11.4% |
| Raffles Medical BSL.SI | Singapore | $1.23B | -13% | -3% | 11% | 1.8× | -2.7% | +6.1% |
| CVS CVSG.L | United Kingdom | $1.22B | +17% | +6% | 11% | 1.7× | 14.2% | +6.9% |
| Huaxia Eye Hospital 301267.SZ | China | $1.78B | -18% | +2% | 15% | 2.1× | 2.1% | +10.4% |
| Yatharth Hospital and Trauma Care Services YATHARTH.NS | India | $1.13B | +31% | +50% | 16% | 7.2× | n/a | n/a |
| Extendicare EXE.TO | Canada | $1.91B | -16% | +36% | 9% | 1.5× | 10.8% | +8.5% |
| Park Medi World PARKHOSPS.NS | India | $1.10B | -4% | +21% | 21% | 5.8× | 22.1% | +10.2% |
| Rhon-klinikum RHK.DE | Germany | $1.06B | +15% | +4% | -51% | 0.6× | n/a | n/a |
| Ardent Health ARDT | United States | $2.03B | +52% | +2% | 5% | 0.6× | -1.7% | +8.7% |
| Brookdale Senior Living BKD | United States | $2.06B | -36% | -8% | 6% | 2.4× | 19.3% | -1.4% |
| Jupiter Life Line Hospitals JLHL.NS | India | $1.01B | +9% | +17% | 16% | 6.0× | n/a | n/a |
| Clinica Baviera CBAV.MC | Spain | $1.01B | +2% | +11% | 20% | 2.8× | 2.3% | +19.7% |
| Ramsay Generale de Sante GDS.PA | France | $969M | -25% | +3% | 4% | 0.9× | 6.1% | +6.0% |
| Paras Healthcare PARASHLTH.NS | India | $962M | n/a | +24% | 11% | 6.4× | n/a | n/a |
| HealthCare Global Enterprises HCG.NS | India | $955M | -7% | +13% | 8% | 3.9× | n/a | n/a |
| Thomson Medical A50.SI | Singapore | $923M | -18% | +6% | 10% | 5.5× | 21.2% | +11.8% |